JMI Syringes & Medical Devices Limited (DSE:JMISMDL)
Bangladesh · Delayed Price · Currency is BDT 136.40
+4.90 (3.73%)
At close: Sep 3, 2026
DSE:JMISMDL Ratios and Metrics
Market cap in millions BDT. Fiscal year is July - June.
Millions BDT. Fiscal year is Jul - Jun.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
| 4,100 | 3,922 | 4,620 | 7,679 | 6,902 | 7,317 | |
Market Cap Growth | -14.70% | -15.09% | -39.84% | 11.27% | -5.68% | 14.37% |
Enterprise Value | 4,020 | 3,888 | 4,640 | 7,854 | 7,120 | 7,429 |
Last Close Price | 136.40 | 129.32 | 151.25 | 250.45 | 225.09 | 236.57 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
PE Ratio | - | 87.32 | 118.82 | - | 68.61 | 82.12 |
PS Ratio | 2.45 | 2.08 | 2.58 | 4.38 | 2.83 | 3.67 |
PB Ratio | 1.64 | 1.50 | 1.77 | 2.96 | 2.51 | 2.70 |
P/TBV Ratio | 1.64 | 1.50 | 1.78 | 2.96 | 2.51 | 2.70 |
P/FCF Ratio | 52.25 | 39.54 | 42.20 | 360.75 | - | 58.63 |
P/OCF Ratio | 45.95 | 36.59 | 37.82 | 116.84 | 169.23 | 39.53 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
EV/Sales Ratio | 2.40 | 2.06 | 2.59 | 4.47 | 2.92 | 3.73 |
EV/EBITDA Ratio | 43.52 | 19.29 | 22.74 | 53.98 | 24.93 | 28.94 |
EV/EBIT Ratio | 150.99 | 28.73 | 34.81 | 110.25 | 33.53 | 40.06 |
EV/FCF Ratio | 51.23 | 39.20 | 42.39 | 368.97 | - | 59.53 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Debt / Equity Ratio | 0.01 | 0.01 | 0.02 | 0.05 | 0.08 | 0.03 |
Debt / EBITDA Ratio | 0.28 | 0.13 | 0.24 | 0.90 | 0.76 | 0.26 |
Debt / FCF Ratio | 0.33 | 0.26 | 0.44 | 6.24 | - | 0.54 |
Net Debt / Equity Ratio | -0.03 | -0.02 | 0.00 | 0.03 | 0.05 | 0.01 |
Net Debt / EBITDA Ratio | -0.87 | -0.28 | 0.03 | 0.56 | 0.44 | 0.08 |
Net Debt / FCF Ratio | -1.02 | -0.58 | 0.05 | 3.81 | -2.22 | 0.17 |
Asset Turnover | 0.55 | 0.63 | 0.60 | 0.55 | 0.75 | 0.62 |
Inventory Turnover | 2.40 | 2.32 | 1.94 | 1.97 | 3.24 | 3.29 |
Quick Ratio | 1.83 | 2.40 | 2.46 | 1.72 | 1.01 | 2.04 |
Current Ratio | 4.34 | 5.68 | 6.25 | 5.12 | 3.36 | 5.53 |
Return on Equity (ROE) | -3.61% | 1.72% | 1.49% | -5.62% | 3.69% | 3.30% |
Return on Assets (ROA) | 0.55% | 2.82% | 2.80% | 1.39% | 4.06% | 3.60% |
Return on Invested Capital (ROIC) | 1.07% | 1.82% | 1.50% | -5.97% | 3.67% | 3.20% |
Return on Capital Employed (ROCE) | 1.00% | 5.00% | 4.90% | 2.60% | 7.50% | 6.60% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Earnings Yield | -2.26% | 1.15% | 0.84% | -1.95% | 1.46% | 1.22% |
FCF Yield | 1.91% | 2.53% | 2.37% | 0.28% | -0.83% | 1.71% |
Dividend Yield | 0.76% | 0.77% | 0.66% | 0.40% | 1.60% | 0.93% |
Payout Ratio | - | 66.85% | 76.48% | - | 68.35% | 73.68% |
Total Shareholder Return | 0.76% | 0.77% | 0.66% | 0.40% | 1.60% | 0.93% |